药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Aluminium monostearate
Ceftezole
The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Ceftezole.
Aluminium monostearate
Cefazedone
The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Cefazedone.
Aluminium monostearate
Cefpirome
The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Cefpirome.
Aluminium monostearate
Cefozopran
The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Cefozopran.
Aluminium monostearate
Cefbuperazone
The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Cefbuperazone.
Aluminium monostearate
Cefetamet
The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Cefetamet.
Aluminium monostearate
Cefsulodin
The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Cefsulodin.
Aluminium monostearate
Cefodizime
The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Cefodizime.
Aluminium monostearate
Cefcapene
The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Cefcapene.
Aluminium monostearate
Cefatrizine
The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Cefatrizine.
Aluminium monostearate
Flomoxef
The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Flomoxef.
Aluminium monostearate
Cefminox
The risk or severity of nephrotoxicity can be increased when Cefminox is combined with Dexibuprofen.
Aluminium monostearate
Ceftaroline fosamil
The risk or severity of nephrotoxicity can be increased when Ceftaroline fosamil is combined with Dexibuprofen.
Aluminium monostearate
Ceftobiprole
The risk or severity of nephrotoxicity can be increased when Ceftobiprole is combined with Dexibuprofen.
Aluminium monostearate
Latamoxef
The risk or severity of nephrotoxicity can be increased when Latamoxef is combined with Dexibuprofen.
Aluminium monostearate
Cephalothin Group
The risk or severity of nephrotoxicity can be increased when Cephalothin Group is combined with Dexibuprofen.
Aluminium monostearate
Hydrolyzed Cephalothin
The risk or severity of nephrotoxicity can be increased when Hydrolyzed Cephalothin is combined with Dexibuprofen.
Aluminium monostearate
Cefpodoxime
The risk or severity of nephrotoxicity can be increased when Cefpodoxime is combined with Dexibuprofen.
Aluminium monostearate
Canrenone
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexibuprofen is combined with Canrenone.
Aluminium monostearate
Canrenoic acid
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Canrenoic acid is combined with Dexibuprofen.